Profuse oral secretions after propafenone administration in neonates.
(2010) The Journal of Pediatrics — Vol. 157, n° 5, p. 856-857 (2010)
Files
2010_Piersigilli_J_Pediatr.pdf
Open Access - Adobe PDF
- 62.22 KB
Details
- Authors
- Abstract
- Propafenone, an antiarrhythmic drug that is effective for treating supraventricular tachycardias, can induce well-known proarrhythmic and systemic adverse effects. We describe a previously unreported adverse effect in 3 newborns: oral propafenone-induced profuse oral secretions and respiratory distress of sufficient severity to necessitate discontinuation of propafenone.
- Affiliations
Bambino Gesù Children’s Hospital – (Italy) Roma Department of Medical and Surgical Neonatology
Citations
Piersigilli, F., Auriti, C., Silvetti, M. S., Marrocco, G., Drago, F., & Seganti, G. (2010). Profuse oral secretions after propafenone administration in neonates. The Journal of Pediatrics, 157(5), 856-857. https://doi.org/10.1016/j.jpeds.2010.06.028 (Original work published 2010)